Robin Kramer

Robin Kramer appears in our data through filings on Biogen Inc. shares, published by SEC (Form 4). The record holds 19 filings, for trades running from 1 July 2021 to 6 February 2026.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

On 10 February 2026 came the latest disclosure, an option exercise in Biogen Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.